14 computational-physics "https:" "https:" "https:" "https:" "Dr" positions at University of Manchester
Sort by
Refine Your Search
-
Listed
-
Category
-
Field
-
Applications are invited for the above post, to start in April 2026 for a fixed term of six months. The successful applicant will work with Dr Alice Thompson on modelling fluid flow and transport in
-
that has not previously been described in the scientific literature. The successful candidate will play a leading role in the project’s experimental programme, developing and carrying out laboratory
-
Research Associate for NIHR funded RfPB study: “A study to determine the design and feasibility of a randomised controlled clinical trial of MOVE SMART - an intervention to increase physical
-
, magnetism and computational studies of low oxidation state rare earth chemistry. This post is part of the project “Interdisciplinary studies of low oxidation state rare earth elements,” supervised by Profs
-
second PDRA undertaking physical and computational studies. For recent publications relevant to the project see: J. Am. Chem. Soc. 2023, 145, 27993; J. Am. Chem. Soc. 2024, 146, 15000; Nat. Commun. 2019
-
. These fellowships are fixed term for 5 years and are an excellent stepping-stone to establishing an independent research career and gaining a full-time permanent academic position. FSE and Rapiscan (https
-
and test new catalysts for nucleophilic aromatic substitution. The performance of top catalysts will be quantified through a series of experimental and computational investigations. The scope
-
interviews: Name: Darren Graham (Dept of Physics and Astronomy) Email: darren.graham@manchester.ac.uk Name: Dr Paul Nutter (Dept of Computer Science) Email: p.nutter@manchester.ac.uk General enquiries: Email
-
leading Pension scheme Excellent employee health and wellbeing services including an Employee Assistance Programme Exceptional starting annual leave entitlement, plus bank holidays Additional paid closure
-
Institute of Biotechnology (MIB) under the ssupervision of Dr Sarah Lovelock. Therapeutic oligonucleotides selectively bind to target mRNA to modulate the production of disease related proteins and have